Cacti Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$29.5K Buy
+1,000
New +$28.6K ﹤0.01% 77
2026
Q2
– Sell
-1,000
Closed -$30K – 77
2026
Q1
$30K Hold
1,000
– – ﹤0.01% 76
2025
Q4
$33.1K Hold
1,000
– – ﹤0.01% 77
2025
Q3
$33.8K Hold
1,000
– – ﹤0.01% 74
2025
Q2
$28K Hold
1,000
– – ﹤0.01% 74
2025
Q1
$25.5K Hold
1,000
– – ﹤0.01% 75
2024
Q4
$27.3K Hold
1,000
– – ﹤0.01% 73
2024
Q3
$28.8K Hold
1,000
– – ﹤0.01% 75
2024
Q2
$25.1K Hold
1,000
– – ﹤0.01% 76
2024
Q1
$27.3K Hold
1,000
– – ﹤0.01% 77
2023
Q4
$40.6K Hold
1,000
– – ﹤0.01% 75
2023
Q3
$34.6K Hold
1,000
– – ﹤0.01% 75
2023
Q2
$40.7K Hold
1,000
– – ﹤0.01% 74
2023
Q1
$38.6K Hold
1,000
– – ﹤0.01% 77
2022
Q4
$44.4K Hold
1,000
– – ﹤0.01% 75
2022
Q3
$43K Hold
1,000
– – ﹤0.01% 77
2022
Q2
$56K Hold
1,000
– – 0.01% 78
2022
Q1
$62K Hold
1,000
– – ﹤0.01% 77
2021
Q4
$55K Hold
1,000
– – ﹤0.01% 76
2021
Q3
$53K Hold
1,000
– – ﹤0.01% 75
2021
Q2
$72K Hold
1,000
– – 0.01% 74
2021
Q1
$77K Hold
1,000
– – 0.01% 76
2020
Q4
$100K Sell
1,000
-1,500
-60% -$183K 0.01% 72
2020
Q3
$355K Buy
+2,500
New +$417K 0.04% 56

Other funds holding LKFT

Cacti Asset Management's LKFT Position: Q3 2026 in Review

Cacti Asset Management opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 1,000 shares worth $29.5K. The stake represents ﹤0.01% of the portfolio and ranks #77 among its holdings. This is a return to the name: Cacti Asset Management previously reported a position in LKFT as recently as Q1 2026.

Cacti Asset Management first reported a position in LKFT in Q3 2020 and has held it in 24 quarters since. The position peaked at $355K in Q3 2020. 13 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • Cacti Asset Management held 1,000 shares of Lakefront Biotherapeutics American Depositary Shares worth $29.5K as of Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Cacti Asset Management position in Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Cacti Asset Management's portfolio in Q3 2026, its #77 holding.
  • Cacti Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2020 and has held it in 24 quarters since.
  • Cacti Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $355K in Q3 2020.
  • 13 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Cacti Asset Management's 13F filing for Q3 2026, filed 1 Oct 2026.